Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Oxford Pharmaceuticals, LLC | Birmingham, AL, United States | Makes it | Problems found, fixed voluntarilyNov 3, 2023 · 3 inspections |
Recalls
- May 5, 2021 · Class II · Oxford Pharmaceuticals, LLC
Presence of Foreign Tablets/Capsules
Lots: Lot #: C21021A, Exp. 03/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buspirone: every company that makes it
- Form
- tablet, oral
- Strength
- 30 mg
- Approval
- ANDA ANDA078302
- On the market since
- May 1, 2020
- Package NDCs
69584-094-0669584-094-1869584-094-50- Official label
- DailyMed (National Library of Medicine), updated Aug 14, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?